美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA206815"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
62135-340-11 62135-340 HUMAN PRESCRIPTION DRUG Sodium Polystyrene Sulfonate Sodium Polystyrene Sulfonate POWDER, FOR SUSPENSION ORAL; RECTAL 20220720 N/A ANDA ANDA206815 Chartwell RX, LLC SODIUM POLYSTYRENE SULFONATE 4.1 meq/g 10 BOTTLE in 1 BOX (62135-340-11) / 15 g in 1 BOTTLE
62135-340-53 62135-340 HUMAN PRESCRIPTION DRUG Sodium Polystyrene Sulfonate Sodium Polystyrene Sulfonate POWDER, FOR SUSPENSION ORAL; RECTAL 20220720 N/A ANDA ANDA206815 Chartwell RX, LLC SODIUM POLYSTYRENE SULFONATE 4.1 meq/g 453.6 g in 1 BOTTLE (62135-340-53)
62135-340-62 62135-340 HUMAN PRESCRIPTION DRUG Sodium Polystyrene Sulfonate Sodium Polystyrene Sulfonate POWDER, FOR SUSPENSION ORAL; RECTAL 20220720 N/A ANDA ANDA206815 Chartwell RX, LLC SODIUM POLYSTYRENE SULFONATE 4.1 meq/g 15 g in 1 BOTTLE (62135-340-62)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase